日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study

小细胞肺癌一线化疗联合免疫疗法:一项双边真实世界研究的结果

Moliner, Laura; Zellweger, Núria; Schmid, Sabine; Bertschinger, Martina; Waibel, Christine; Cerciello, Ferdinando; Froesch, Patrizia; Mark, Michael; Bettini, Adrienne; Häuptle, Pirmin; Blum, Veronika; Holer, Lisa; Hayoz, Stefanie; Früh, Martin; Ahmed, Samreen; Bhagani, Shradha; Steele, Nicola; Gray, Hannah-Leigh; Robinson, Stephen D; Davidson, Michael; Cox, Samantha; Khalid, Taha; Geldart, Tom R; Nolan, Luke; Scott, Deborah C; Hennah, Lindsay; Newsom-Davis, Tom; Rathbone, Emma; Handforth, Catherine; Denton, Arshi; Merchant, Shairoz; Blackhall, Fiona; Mauti, Laetitia A; Califano, Raffaele; Rothschild, Sacha I

Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment

接受伊匹木单抗联合纳武利尤单抗一线或二线治疗的恶性胸膜间皮瘤患者的真实世界疗效

Schmid, Sabine; Holer, Lisa; Gysel, Katrin; Koster, Kira-Lee; Rothschild, Sacha I; Boos, Laura A; Frehner, Lorenz; Cardoso Almeida, Sabine; Britschgi, Christian; Metaxas, Yannis; Mark, Michael; Froesch, Patrizia; Janthur, Wolf-Dieter; Allemann, Anna; Waibel, Christine; Von der Mühll-Schill, Catherine; Früh, Martin; Mauti, Laetitia A

Erectile function preservation after salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: Five-year results of the SAKK 09/10 randomized phase 3 trial

前列腺癌根治术后生化复发患者接受挽救性放疗后勃起功能保留情况:SAKK 09/10随机3期试验的五年结果

Zwahlen, Daniel R; Schröder, Christina; Holer, Lisa; Bernhard, Jürg; Hölscher, Tobias; Arnold, Winfried; Polat, Bülent; Hildebrandt, Guido; Müller, Arndt-Christian; Martin Putora, Paul; Papachristofilou, Alexandros; Schär, Corinne; Hayoz, Stefanie; Sumila, Marcin; Zaugg, Kathrin; Guckenberger, Matthias; Ost, Piet; Giovanni Bosetti, Davide; Reuter, Christiane; Gomez, Silvia; Khanfir, Kaouthar; Beck, Marcus; Thalmann, George N; Aebersold, Daniel M; Ghadjar, Pirus

A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer

一项针对晚期三阴性乳腺癌患者的多中心II期临床试验,研究载有阿霉素的抗EGFR免疫脂质体的疗效

Mamot, Christoph; Wicki, Andreas; Hasler-Strub, Ursula; Riniker, Salome; Li, Qiyu; Holer, Lisa; Bärtschi, Daniela; Zaman, Khalil; von Moos, Roger; Dedes, Konstantin J; Boos, Laura A; Novak, Urban; Bodmer, Alexandre; Ritschard, Reto; Obermann, Ellen C; Tzankov, Alexandar; Ackermann, Christoph; Membrez-Antonioli, Véronique; Zürrer-Härdi, Ursina; Caspar, Clemens B; Deuster, Stefanie; Senn, Martin; Winterhalder, Ralph; Rochlitz, Christoph